Did you know? We’ve partnered with Ippon Technologies to launch Data Sips, a video miniseries showcasing quick conversations with industry experts that took place during last month’s Data Governance & Information Quality (DGIQ) Conference in Washington, D.C. The first episode features DATAVERSITY founder and CEO Tony Shaw chatting with host Steve MacLauchlan, head of data at Ippon. (Steve also hosts a longer version of the series called The Data Pour,…

Read more about author Hiral Rana. Clinical trials for medical devices hold a unique significance due to their direct application in patient care and the rigorous scrutiny they undergo from regulatory bodies. Unlike pharmaceutical trials, medical device trials involve complex interactions between hardware, software, and human factors. This complexity is compounded by the high stakes associated with ensuring patient safety, making robust data management essential for medical device clinical trials.…

Read more about author Gaurav Belani. Large language models (LLMs) are the backbone of modern natural language processing. They predict words, craft sentences, and mimic human language at scale. But underneath their polished outputs lies a limitation: They only replicate patterns seen in their given or training data. What happens when we want LLMs to go beyond this – when they need to learn, adapt, and refine their outputs in…

Read more about author Angel Viña. Businesses engage in mergers and acquisitions (M&A) to gain new capabilities, remove competitors, reduce operational costs, and join new markets. In the first half of 2024, the global value of M&A activity was $1.0 trillion, 4% higher than it was during the same period last year. M&A requires meticulous attention to regulatory and compliance issues. Navigating these challenges effectively can mean the difference between a successful…